wavemovies Wix.com ( WIX ) was downgraded to Underweight from Neutral at J.P. Morgan, as the investment firm said it has concerns about its core business. Shares fell 1% in premarket trading. “While we like that the company is leaning further towards investment-led vibe-coding differentiation, our conviction to the investment case has diminished on signs of core business revenue growth deceleratio...
wavemovies Wix.com ( WIX ) was downgraded to Underweight from Neutral at J.P. Morgan, as the investment firm said it has concerns about its core business. Shares fell 1% in premarket trading. “While we like that the company is leaning further towards investment-led vibe-coding differentiation, our conviction to the investment case has diminished on signs of core business revenue growth deceleration,” analyst Alexei Gogolev wrote in a note to clients. “We think that margin improvement will be slower and more volatile than investors anticipate. Longer-term, we view the website and e-commerce management space facing structurally more technology-driven competition compared to other parts of our coverage.” In addition to the downgrade, Gogolev lowered his price target on Wix to $91 from $114. Delving deeper, Gogolev said that Wix appears to be “increasingly dependent” on its Base44 unit, which lets customers build artificial intelligence-powered apps in short order. And while the growth has been impressive (annual recurring revenue went from a few million dollars in the middle of 2025 to above $100M as of March), the company's core Creative Subscriptions business (excluding Base44) is likely to slow down to roughly 6% growth this year, down from about 10% in 2025. Gogolev also noted that sales and marketing expenses are likely to increase, and the fact that roughly one-third of Base44's inference costs are attributed to free users. The company is also likely to face a higher cost base, partly because part of its expenses are in the Israeli shekel, which has appreciated compared to the U.S. dollar. More on Wix.com Wix.com: No AI Apocalypse In Sight, Only Tailwinds (Upgrade) Wix.com: Maybe Not A Clear Buy, But Worth Selling A Put Option Wix.com Ltd. (WIX) Q4 2025 Earnings Call Transcript Wix.com launches $1.75B modified Dutch auction to buy back shares at $80–$92 Wix outlines mid-teens revenue growth for 2026 as AI strategy accelerates, Base44 surpasses $100M ARR
Kopin press release ( KOPN ): Q4 Revenue of $8.4M (-42.5% Y/Y) misses by $2.55M . Product revenues for the fourth quarter were $5.6 million, as compared to $12.6 million in the year-ago period. Non-Product revenues were $2.5 million in the fourth quarter of 2025, as compared to $1.7 million in the fourth quarter of 2024. As of December 27, 2025, the company had cash and cash equivalents of $37.8 m...
Kopin press release ( KOPN ): Q4 Revenue of $8.4M (-42.5% Y/Y) misses by $2.55M . Product revenues for the fourth quarter were $5.6 million, as compared to $12.6 million in the year-ago period. Non-Product revenues were $2.5 million in the fourth quarter of 2025, as compared to $1.7 million in the fourth quarter of 2024. As of December 27, 2025, the company had cash and cash equivalents of $37.8 million. More on Kopin Kopin: Speculative Upside Could Require More Catalyst Kopin wins U.S. Phase I SBIR contract for MicroLED display development Kopin receives $2 million order for helmet-mounted display system from European defense contractor Seeking Alpha’s Quant Rating on Kopin Historical earnings data for Kopin
The organisers of a leading artificial intelligence conference have apologised after a new policy that appeared to bar US-sanctioned entities from participating sparked a backlash in China, saying the ban was more limited than initially indicated. The apology came after several major Chinese professional bodies urged domestic researchers to boycott the event, amid concerns that prominent tech grou...
The organisers of a leading artificial intelligence conference have apologised after a new policy that appeared to bar US-sanctioned entities from participating sparked a backlash in China, saying the ban was more limited than initially indicated. The apology came after several major Chinese professional bodies urged domestic researchers to boycott the event, amid concerns that prominent tech groups such as Huawei Technologies would be excluded. In a statement on Friday, the Conference on Neural...
Bonjour et Bienvenue to the Paris Edition. I’m Bloomberg Opinion columnist Lionel Laurent . If you haven’t yet, subscribe now to the Paris Edition newsletter . No Winners This week’s French local elections were largely a sideshow next to the war in Iran, which threatens to push up inflation and hurt growth in Europe’s No. 2 economy. But they did offer an important test of the national mood a littl...
Bonjour et Bienvenue to the Paris Edition. I’m Bloomberg Opinion columnist Lionel Laurent . If you haven’t yet, subscribe now to the Paris Edition newsletter . No Winners This week’s French local elections were largely a sideshow next to the war in Iran, which threatens to push up inflation and hurt growth in Europe’s No. 2 economy. But they did offer an important test of the national mood a little over a year away from presidential elections that will have a large influence on the future direction of the continent. While the scattered nature of the results means no party can convincingly say it “won,” there are small signs of hope for the political center in its uphill struggle to beat the extremes. The most surprising outcome is maybe that there were very few surprises. The momentum going into the election appeared to belong to Marine Le Pen’s National Rally, provoking a lot of speculation that the far right might win a big prize such as a major city. But in the end even Le Pen had to admit she was “disappointed” by the results, with the party falling short in its bid to take control of Marseille, Toulon and Nimes. While there was an increase in the overall number of municipalities won, there wasn’t a breakthrough. While the result may yet change in a national election, it does seem that voters are wavering when it comes to handing more power to Le Pen and No. 2 Jordan Bardella. One reason might be the proximity of European populist parties to the Trump administration, which has thrown its support behind conservative euroskeptics including the National Rally leader. After months of US threats over Greenland, saber-rattling over trade and now a war in the Middle East, voters may be less convinced in the merits of MAGA’s authoritarian mode and its rejection of European integration. As for Jean-Luc Melenchon’s far left, despite still proving popular in the inner-city-esque suburbs like Seine Saint-Denis, it failed to clinch any big cities; its total vote share after ...
OnKure Therapeutics ( OKUR ) announced on Friday that it had agreed to raise about $150M in a private placement from institutional and healthcare investors. In connection with the financing, Liam Ratcliffe will join the board of the company. Pursuant to the agreement, the company will sell 26.71M Class A shares at $4.15 each and, in lieu of stock, pre-funded warrants for 9.43M shares at $4.1499 ap...
OnKure Therapeutics ( OKUR ) announced on Friday that it had agreed to raise about $150M in a private placement from institutional and healthcare investors. In connection with the financing, Liam Ratcliffe will join the board of the company. Pursuant to the agreement, the company will sell 26.71M Class A shares at $4.15 each and, in lieu of stock, pre-funded warrants for 9.43M shares at $4.1499 apiece, with the warrants exercisable immediately at $0.0001 per share. The offering is expected to close on March 31, 2026. The company plans to use net proceeds to advance development of its next-generation PI3Kα inhibitor candidates in breast cancer and vascular anomalies, as well as for working capital and general corporate purposes. Leerink Partners is acting as lead placement agent for the financing. Evercore ISI, LifeSci Capital, and Oppenheimer & Co. are serving as co-placement agents for the financing. Shares +14.75%. More on OnKure Therapeutics OnKure Therapeutics GAAP EPS of -$0.09 Seeking Alpha’s Quant Rating on OnKure Therapeutics Historical earnings data for OnKure Therapeutics Financial information for OnKure Therapeutics
(RTTNews) - Sturm, Ruger & Co., Inc. (RGR), a firearm manufacturing company, on Friday announced that Chief Financial Officer Tom Dineen will step down, with Andrew Wieland appointed as Senior Vice President and Chief Financial Officer.
(RTTNews) - Sturm, Ruger & Co., Inc. (RGR), a firearm manufacturing company, on Friday announced that Chief Financial Officer Tom Dineen will step down, with Andrew Wieland appointed as Senior Vice President and Chief Financial Officer.
Wolterk Irenic Capital Management, one of the largest shareholders of Teleflex ( TFX ), sent a letter to the medical device maker on Friday urging the company to explore strategic alternatives, including a potential buyout, and revamp its board. In the letter signed by its top executives, including co-founder Adam Katz, Irenic noted that the company, which has delivered a negative shareholder retu...
Wolterk Irenic Capital Management, one of the largest shareholders of Teleflex ( TFX ), sent a letter to the medical device maker on Friday urging the company to explore strategic alternatives, including a potential buyout, and revamp its board. In the letter signed by its top executives, including co-founder Adam Katz, Irenic noted that the company, which has delivered a negative shareholder return of 73% over the past five years, should engage would-be acquirors. The letter came after Teleflex ( TFX ) chairman Stephen Klasko, during a meeting last week, informed Irenic that the board has directed its advisors not to accept approaches from potential bidders. Additionally, the New York-based hedge fund pointed to a lack of insider purchases by the Teleflex ( TFX ) board and argued that the company requires changes at the board, notably a new chair. “In fact, this Board, collectively tenured nearly eighty years, has purchased a grand total of 8,250 shares of Teleflex on the open market,” Irenic, which holds a 2% stake in the company, wrote. It added that the “board failed at its primary job—properly planning for succession” as the company operates without a permanent CEO. “It is time—well past time—for the board to take a more constructive and responsible approach and begin engaging with credible acquirors," the executives concluded. More on Teleflex Teleflex: More Clarity And More Questions Teleflex Incorporated 2025 Q4 - Results - Earnings Call Presentation Teleflex Incorporated (TFX) Q4 2025 Earnings Call Transcript Teleflex outlines $6.25–$6.55 EPS guidance for 2026 amid portfolio transformation and $1B share repurchase plan Teleflex reports Q4 results